세계의 헬스케어용 블록체인 시장 : 업계 동향 및 예측 - 블록체인 유형별, 최종 사용자 유형별, 주요 지역별

Blockchain in Healthcare Market: Industry Trends and Global Forecasts - Distribution by Type of Blockchain Type of End-User and Key Geographical Regions

US $ 4,799 ￦ 6,747,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,999 ￦ 9,840,000

PDF (One-Location Site License)

PDF 보고서를 동일 사업장의 특정 사업 부문에 속한 모든 분들이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,599 ￦ 14,902,000

PDF (Department License)

PDF 보고서를 부서 단위로 12명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 17,999 ￦ 25,306,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 헬스케어용 블록체인 시장 : 개요

세계의 헬스케어용 블록체인 시장 규모는 2035년까지 예측 기간 동안 22.8%의 연평균 복합 성장률(CAGR)로 확대될 전망이며, 현재 6,700만 달러에서 2035년까지 6억 4,100만 달러로 성장할 것으로 예측됩니다.

시장 세분화는 시장 규모 및 기회 분석을 다음 매개 변수로 구분합니다.

블록체인 유형별

• 퍼블릭 블록체인
• 프라이빗 블록체인
• 하이브리드 블록체인
• 기타

최종 사용자 유형별

• 병원
• 제약업계
• 연구기관
• 학술기관

주요 지역별

• 북미
• 유럽
• 아시아태평양
• 기타 지역

세계의 헬스케어용 블록체인 시장 : 성장 및 동향

최근 블록체인은 은행, 공급망 관리, 헬스케어 등 다양한 업계에서 분산형 금전 거래 및 데이터 교환을 위한 다목적 도구로 입증되었기 때문에 업계 관계자뿐만 아니라 연구자로부터도 큰 관심을 모으고 있습니다. 헬스케어의 몇몇 이해관계자들은 환자 기록 관리, 임상시험을 위한 환자 모집, 공급망의 투명성 및 추적성 제공 등 다양한 업무에 블록체인을 채택하고 있습니다. 또한 의약품의 라이프 사이클 관리를 대폭 개선하는 방법으로서 효과적이고 잠재적으로 이용할 수 있습니다. 헬스케어용 블록체인은 점차 큰 이점을 발휘함으로써 전례 없는 기회를 공개해 왔습니다.

블록체인 기술에 대한 이해관계자의 관심은 높아지고 있지만, 확장성 문제, 보안 부족, 사이버 공격 등 몇 가지 과제를 안고 있습니다. 전술한 과제에 대처하기 위해 조직은 투명성 및 프라이버시를 확립하고 기밀성이 높은 환자 데이터를 숨기는 한편 필요한 경우에만 액세스를 허용하고 있습니다. 나아가 선진적인 플랫폼을 개발하고자 하는 업계 진입 기업들의 지속적인 노력에 힘입어 세계의 블록체인 시장은 예측되는 미래에 큰 속도로 성장할 것으로 예상됩니다.

세계의 헬스케어용 블록체인 시장 : 주요 인사이트

이 보고서는 세계 헬스케어용 블록체인 시장의 현재 상태를 파악하고 업계 내 잠재적 성장 기회를 확인합니다. 본 보고서의 주요 조사 결과는 다음과 같습니다.

• 현재, 50사 이상의 기업이 폭넓은 의약품 개발에 있어서 블록체인 플랫폼 솔루션을 제공하고 있다고 주장하고 있습니다.
• 현재 시장 상황은 다양한 의약품 개발용으로 블록체인 기술을 업계에 제공하고 있는 이해관계자를 특징으로 하며, 이러한 기술 플랫폼의 대부분은 임상시험 관리에 이용되고 있습니다.

• 이해관계자는 경쟁 우위를 구축하기 위해 기존 기능을 강화하고 첨단 기능을 갖춘 독자적인 블록체인 플랫폼 업그레이드에 노력하고 있습니다.
• 제약 업계에서 블록체인 기술의 이용에 초점을 맞춘 논문의 약 37%는 최근 발표된 것으로 조사별 실질적인 대처가 부각되고 있습니다.
• 최근 몇 년간 블록체인과 관련된 논문수는 크게 증가하고 있으며 최근에는 130개의 논문이 발표되었습니다.
• 이 분야의 출판물의 대부분(-60%)은 의약품 공급망 및 임상시험 관리에 있어서의 블록체인의 이용 평가에 초점을 맞춘 조사 논문입니다.
• 이해관계자의 관심이 높아지고 있는 것은 최근의 파트너십 활동의 활발화에서도 찾아볼 수 있습니다. 지금까지 거래의 60%는 자체 블록체인 플랫폼의 활용과 통합에 초점을 맞추고 있습니다.
• 지난 몇 년간, 이 분야에서의 파트너십 활동은 CAGR 73% 이상으로 증가하고 있어 거래의 대부분은 플랫폼 이용 계약이었습니다.
• 대륙간 거래의 대부분은 북미와 유럽을 거점으로 하는 진입기업간에 체결되고 있으며, 이러한 파트너십의 25%는 2022년에 체결되고 있습니다.
• 임상연구, 특히 창약 및 임상시험에서 블록체인 수요 증가는 이 분야의 진입기업에 유리한 비즈니스 기회를 가져올 것으로 예측됩니다.
• 이 시장은 향후 10년간 연률 22%의 성장을 이룰 것으로 예상되며, 그 기회는 다양한 유형의 블록체인, 최종 사용자의 유형, 주요 지리적 지역에 잘 분산될 것으로 보입니다.

세계의 헬스케어용 블록체인 시장 : 주요 부문

블록체인 유형별로 시장은 퍼블릭 블록체인, 프라이빗 블록체인, 하이브리드 블록체인 등으로 구분됩니다. 현재 프라이빗 블록체인 부문이 전 세계 헬스케어용 블록체인 시장에서 최대(-40%)의 점유율을 차지하고 있습니다. 게다가 퍼블릭 블록체인 부문은 다른 세그먼트와 비교해 빠른 속도로 성장할 가능성이 높습니다.

최종 사용자 유형별로 시장은 병원, 제약 업계, 연구 기관 및 학술 기관으로 구분됩니다. 현재 병원 부문이 건강 시장에서 블록 체인에서 가장 높은 비율(- 40%)을 차지하고 있습니다. 게다가 제약 산업 부문은 비교적 높은 CAGR로 성장할 가능성이 높습니다.

주요 지역별로 볼 때 시장은 북미, 유럽, 아시아태평양 및 기타 지역으로 구분됩니다. 현재 아시아태평양(40% 이상)은 건강 관리의 블록 체인 시장을 독점하고 최대 수익 점유율을 차지하고 있습니다. 그러나 세계 다른 지역의 시장은 더 높은 CAGR로 성장할 것으로 예상되고 있습니다.

헬스케어용 블록체인 시장 진출 기업의 예

• Alten Calsoft Labs
• ConsenSys
• Humanscape
• Hyperledger Foundation
• IBM
• Infosys
• Innoplexus
• Medsphere
• Solulab
• Stratumn
• Tech Mahindra

이 보고서는 세계의 헬스케어용 블록체인 시장을 조사했으며, 시장 개요와 함께 블록체인 유형별, 최종 사용자 유형별 동향, 지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.

목차

제1장 서문

제2장 주요 요약

제3장 서문

• 장의 개요
• 블록체인 기술 개요
• 블록체인 유형
• 다양한 업계에서 블록체인 용도
• 창약 및 임상시험에서 블록체인 용도
• 블록체인의 장점 및 한계
• 장래의 전망

제4장 시장 개요

• 장의 개요
• 블록체인 기술 공급자 목록

제5장 기업 경쟁력 분석

• 장의 개요
• 전제 및 주요 파라미터
• 조사 방법
• 기업 경쟁력 분석 : 북미에 거점을 두는 블록체인 기술 제공업체(피어 그룹 I)
• 기업 경쟁력 분석 : 유럽에 본사를 둔 블록체인 기술 공급자(피어 그룹 II)
• 기업 경쟁력 분석 : 아시아태평양 및 기타 지역에 본사를 둔 블록체인 기술 공급자(피어 그룹 III)

제6장 기업 프로파일

• 장의 개요
• Alten Calsoft Labs
• ConsenSys
• IBM
• Stratumn
• Infosys
• Tech Mahindra
• Humanscape
• Hyperledger Foundation
• Innoplexus
• Medsphere
• Solulab

제7장 파트너십 및 협업

• 장의 개요
• 파트너십 모델
• 창약 및 임상시험에서 블록체인 : 최근의 파트너십 및 협업

제8장 출판물 분석

제9장 SWOT 분석

• 장의 개요
• 창약 및 임상시험에서 블록체인 : SWOT 분석
• SWOT 요인의 비교

제10장 사례 연구 : 의료 및 기타 산업에서 블록체인 적용

• 장의 개요
• 다양한 업계에서 블록체인 용도
  • 헬스케어용 블록체인
  • 은행 및 금융업계의 블록체인
  • 자동차 업계의 블록체인
  • 교육의 블록체인
  • 통신 업계의 블록체인
  • 교통의 블록체인
  • 여행업계의 블록체인

제11장 시장 예측 및 기회 분석

• 장의 개요
• 주요 전제와 조사 방법
• 창약 및 임상시험 시장에서 블록체인(-2035년)
• 창약 및 임상시험 시장에서 블록체인 : 블록 체인 유형별
• 창약 및 임상시험 시장에서 블록체인 : 최종 사용자별
• 창약 및 임상시험 시장에서 블록체인 : 주요 지역별

제12장 결론

제13장 주요 인사이트

제14장 부록 1 : 표 형식 데이터

제15장 부록 2 : 기업 및 단체 일람

AJY

영문 목차

영문목차

GLOBAL BLOCKCHAIN IN HEALTHCARE MARKET: OVERVIEW

As per Roots Analysis, the global blockchain in healthcare market is estimated to grow from USD 67 million in the current year to USD 641 million by 2035, at a CAGR of 22.8% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Blockchain

• Public Blockchain
• Private Blockchain
• Hybrid Blockchain
• Other Blockchains

Type of End User

• Hospitals
• Pharmaceutical Industry
• Research Institutes
• Academic Institutes

Key Geographical Regions

• North America
• Europe
• Asia-Pacific
• Rest of the World

GLOBAL BLOCKCHAIN IN HEALTHCARE MARKET: GROWTH AND TRENDS

In recent years, blockchain has garnered significant interest from researchers, as well as industry players, as it has proven to be a versatile tool for decentralized monetary transactions and data exchange in various industries, such as banking, supply chain management and healthcare. Several stakeholders in healthcare have adopted blockchain for various operations, such as in maintaining patient records, in recruiting patients for trials and providing transparency and traceability during the supply chain. Moreover, it can effectively and potentially be used as a method to significantly improve the drug life cycle management. Gradually, blockchain in healthcare has disclosed unprecedented opportunities by unlocking significant advantages.

Despite the growing interest of stakeholders in blockchain technology, it is associated with several challenges, including scalability issues, lack of security and cyber-attacks. In order to deal with the aforementioned challenges, organizations have established transparency and privacy to conceal sensitive patient data while allowing access, only when required. Further, driven by the continuous efforts of industry players to develop advanced platforms, we anticipate that the global blockchain market is likely to grow at a significant pace in the foreseen future

GLOBAL BLOCKCHAIN IN HEALTHCARE MARKET: KEY INSIGHTS

The report delves into the current state of global blockchain in the healthcare market and identifies potential growth opportunities within industry. Some key findings from the report include:

• Presently, more than 50 players claim to provide blockchain platform solutions across a wide range of drug development applications.
• The current market landscape features stakeholders offering blockchain technology to industries for various drug development applications; majority of these technology platforms are being used for clinical trial management.

• In pursuit of building a competitive edge, stakeholders are striving to enhance their existing capabilities and upgrade their proprietary blockchain platforms with advanced features.
• Around 37% of the articles focused on the use of blockchain technology in the pharmaceutical industry have been published recently, highlighting the substantial efforts undertaken by researchers.
• Over the years, there has been a significant increase in the number of publications related to blockchain; 130 articles have been published recently.
• Majority (~60%) of the publications in this domain are research articles focused on evaluating the use of blockchain in drug supply chain and clinical trial management.
• The growing interest of stakeholders is also prevalent from the recent rise in partnership activity; ~60% of the deals, so far, have been focused on utilization and integration of proprietary blockchain platforms.
• In the past few years, the partnership activity in this domain has increased at a CAGR of over 73%; majority of the deals were platform utilization agreements.
• Majority of the intercontinental deals have been inked between players based in North America and Europe; 25% of these partnerships have been signed in 2022.
• The increasing demand for blockchain in clinical research, especially for drug discovery and clinical trials, is anticipated to create lucrative business opportunities for players within this field.
• We expect the market to witness an annualized growth of 22% in the coming decade; the opportunity is likely to be well distributed across various types of blockchain, types of end-users and key geographical regions.

GLOBAL BLOCKCHAIN IN HEALTHCARE MARKET: KEY SEGMENTS

Private blockchain Segment Occupies the Largest Share of the Blockchain in Healthcare Market

Based on the type of blockchain, the market is segmented into public blockchain, private blockchain, hybrid blockchain, and other blockchains. At present, the private blockchain segment holds the maximum (~40%) share of the global blockchain in the healthcare market. Additionally, the public blockchain segment is likely to grow at a faster pace compared to the other segments.

By Type of End User, Pharmaceutical Industry Segment is the Fastest Growing Segment of the Global Blockchain in Healthcare Market

Based on the type of end user, the market is segmented into hospitals, pharmaceutical industry, research institutes and academic institutes. Currently, hospitals segment captures the highest proportion (~40%) of the blockchain in the healthcare market. Further, the pharmaceutical industry segment is likely to grow at a relatively higher CAGR.

Asia-Pacific Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific and Rest of the World. Currently, Asia-Pacific (>40%) dominates the blockchain in healthcare market and accounts for the largest revenue share. However, the market in the rest of the world is expected to grow at a higher CAGR.

Example Players in the Blockchain in Healthcare Market

• Alten Calsoft Labs
• ConsenSys
• Humanscape
• Hyperledger Foundation
• IBM
• Infosys
• Innoplexus
• Medsphere
• Solulab
• Stratumn
• Tech Mahindra

GLOBAL BLOCKCHAIN IN HEALTHCARE MARKET: RESEARCH COVERAGE

• Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global blockchain in healthcare market, focusing on key market segments, including [A] type of blockchain, [B] type of end user and [C] key geographical regions.
• Market Landscape: A comprehensive evaluation of healthcare companies using blockchain technology for drug discovery and clinical trials, considering various parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters, [D] type of blockchains, [E] type of drug development applications, [F] applications within clinical trial management and [G] type of end users.
• Company Competitiveness Analysis: A comprehensive company competitive analysis of blockchain technology providers, examining factors, such as [A] supplier strength, [B] portfolio diversity and [C] portfolio strength.
• Company Profiles: In-depth profiles companies providing blockchain platforms for drug discovery applications, focusing on [A] company overview, [B] financial information (if available), [C] details on application areas of proprietary platform, and [D] recent developments and an informed future outlook.
• Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in the blockchain in healthcare market, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] type of partner, [D] type of pharmaceutical applications, [E] most active players (in terms of the number of partnerships signed) and [F] geography.
• Publication Analysis: An insightful analysis of more than 500 peer-reviewed scientific articles focused on blockchain in the pharmaceutical industry, based on various relevant parameters, such as [A] year of publication, [B] type of publication, [C] popular publishers, [D] popular copyright holders and [E] keywords.
• SWOT Analysis: An analysis of industry affiliated trends, opportunities and challenges, which are likely to impact the evolution of blockchain in healthcare market; it includes a Harvey ball analysis, assessing the relative impact of each SWOT parameter on industry dynamics.
• Case Study: A detailed discussion highlighting the applications of blockchain across various industries, such as [A] healthcare, [B] banking and financial, [C] automotive, [D] education, [E] telecom, [F] transportation and [G] travel industries.

KEY QUESTIONS ANSWERED IN THIS REPORT

• How many companies are currently engaged in this market?
• Which are the leading companies in this market?
• What factors are likely to influence the evolution of this market?
• What is the current and future market size?
• What is the CAGR of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

• Complimentary PPT Insights Packs
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 15% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

• 1.1. Scope of the Report
• 1.2. Research Methodology
  • 1.2.1. Research Assumptions
  • 1.2.2. Project Methodology
  • 1.2.3. Forecast Methodology
  • 1.2.4. Robust Quality Control
  • 1.2.5. Key Considerations
    • 1.2.5.1. Demographics
    • 1.2.5.2. Economic Factors
    • 1.2.5.3. Government Regulations
    • 1.2.5.4. Supply Chain
    • 1.2.5.5. COVID Impact / Related Factors
    • 1.2.5.6. Market Access
    • 1.2.5.7. Healthcare Policies
    • 1.2.5.8. Industry Consolidation
• 1.3 Key Questions Answered
• 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

• 2.1. Chapter Overview

3. INTRODUCTION

• 3.1. Chapter Overview
• 3.2. Overview of Blockchain Technology
  • 3.2.1. Ethereum vs Hyperledger Fabric
• 3.3. Types of Blockchain
  • 3.3.1. Permissionless or Public Blockchain
  • 3.3.2. Permission or Private Blockchain
  • 3.3.3. Federated or Consortium Blockchain
• 3.4. Applications of Blockchain Across Various Industries
• 3.5. Applications of Blockchain in Drug Discovery and Clinical Trials
• 3.6. Advantages and Limitations of Blockchain
• 3.7. Future Perspectives

4. MARKET OVERVIEW

• 4.1. Chapter Overview
• 4.2. List of Blockchain Technology Providers
  • 4.2.1. Analysis by Year of Establishment
  • 4.2.2. Analysis by Company Size
  • 4.2.3. Analysis by Region of Headquarters
  • 4.2.4. Analysis by Location of Headquarters
  • 4.2.5. Analysis by Year of Establishment, Company Size, and Region of Headquarters
  • 4.2.6. Analysis by Type of Blockchain(s)
  • 4.2.7. Analysis by Type of Drug Development Application(s)
  • 4.2.8. Analysis by Application(s) within Clinical Trial Management
  • 4.2.9. Analysis by Type of End-User(s)
  • 4.2.10. Analysis by Type of Blockchain and Type of End-User(s)
  • 4.2.11. Analysis by Type of Blockchain and Type of Drug Development Application(s)

5. COMPANY COMPETITIVENESS ANALYSIS

• 5.1. Chapter Overview
• 5.2. Assumptions / Key Parameters
• 5.3. Methodology
• 5.4. Company Competitiveness Analysis: Blockchain Technology Providers based in North America (Peer Group I)
• 5.5. Company Competitiveness Analysis: Blockchain Technology Providers based in Europe (Peer Group II)
• 5.6. Company Competitiveness Analysis: Blockchain Technology Providers based in Asia Pacific and RoW (Peer Group III)

6. COMPANY PROFILES

• 6.1. Chapter Overview
• 6.2. Alten Calsoft Labs
  • 6.2.1. Company Overview
  • 6.2.2. Financial Information
  • 6.2.3. Application Areas of Proprietary Platform
  • 6.2.4. Recent Developments and Future Outlook
• 6.3. ConsenSys
  • 6.3.1. Company Overview
  • 6.3.2. Application Areas of Proprietary Platform
  • 6.3.3. Recent Developments and Future Outlook
• 6.4. IBM
  • 6.4.1. Company Overview
  • 6.4.2. Financial Information
  • 6.4.3. Application Areas of Proprietary Platform
  • 6.4.4. Recent Development and Future Outlooks
• 6.5. Stratumn
  • 6.5.1. Company Overview
  • 6.5.2. Application Areas of Proprietary Platform
  • 6.5.3. Recent Development and Future Outlook
• 6.6. Infosys
  • 6.6.1. Company Overview
  • 6.6.2. Financial Information
  • 6.6.3. Application Areas of Proprietary Platform
  • 6.6.4. Recent Developments and Future Outlook
• 6.7. Tech Mahindra
  • 6.7.1. Company Overview
  • 6.7.2. Financial Information
  • 6.7.3. Application Areas of Proprietary Platform
  • 6.7.4. Recent Developments and Future Outlook
• 6.8. Humanscape
  • 6.8.1. Company Overview
  • 6.8.2. Application Areas of Proprietary Platform
  • 6.8.3. Recent Developments and Future Outlook
• 6.9. Hyperledger Foundation
  • 6.9.1. Company Overview
  • 6.9.2. Application Areas of Proprietary Platform
  • 6.9.3. Recent Developments and Future Outlook
• 6.10. Innoplexus
  • 6.10.1. Company Overview
  • 6.10.2. Application Areas of Proprietary Platform
  • 6.10.3. Recent Developments and Future Outlook
• 6.11. Medsphere
  • 6.11.1. Company Overview
  • 6.11.2. Application Areas of Proprietary Platform
  • 6.11.3. Recent Developments and Future Outlook
• 6.12. Solulab
  • 6.12.1. Company Overview
  • 6.12.2. Application Areas of Proprietary Platform
  • 6.12.3. Recent Developments and Future Outlook

7. PARTNERSHIPS AND COLLABORATIONS

• 7.1. Chapter Overview
• 7.2. Partnership Models
• 7.3. Blockchain in Drug Discovery and Clinical Trials: Recent Partnerships and Collaborations
  • 7.3.1. Analysis by Year of Partnership
  • 7.3.2. Analysis by Type of Partnership
  • 7.3.3. Analysis by Year and Type of Partnership
  • 7.3.4. Analysis by Company Size and Type of Partnership
  • 7.3.5. Most Active Players: Distribution by Number of Partnerships
  • 7.3.6. Most Active Players: Distribution by Type of Partnership
  • 7.3.7. Analysis by Type of Pharmaceutical Applications
  • 7.3.8. Analysis by Type of Partner
  • 7.3.9. Analysis by Geographical Region
    • 7.3.9.1. Local and International Agreements
    • 7.3.9.2. Intercontinental and Intracontinental Agreements

8. PUBLICATION ANALYSIS

• 8.1. Chapter Overview
• 8.2. Scope and Methodology
• 8.3. Blockchain Technology in Pharmaceutical Industry: Recent Publications
  • 8.3.1. Analysis by Year of Publication
  • 8.3.2. Analysis by Type of Article
  • 8.3.3. Popular Journals: Analysis by Number of Publications
  • 8.3.4. Popular Publishers: Analysis by Number of Publications
  • 8.3.5. Popular Copyright Holders: Analysis by Number of Publications
  • 8.3.6. Analysis by Popular Keywords
  • 8.3.7. Analysis by Impact Factor
  • 8.3.8. Popular Journals: Analysis by Journal Impact Factor

9. SWOT ANALYSIS

• 9.1. Chapter Overview
• 9.2. Blockchain in Drug Discovery and Clinical Trials: SWOT Analysis
• 9.3. Comparison of SWOT Factors
  • 9.3.1. Strengths
    • 9.3.1.1. Transparency and Traceability
    • 9.3.1.2. Cost Reduction and Data Integrity
    • 9.3.1.3. Safe and Secure Transactions
    • 9.3.1.4. Patient Data Management
  • 9.3.2. Weaknesses
    • 9.3.2.1. Implementation Expense
    • 9.3.2.2. Storage
    • 9.3.2.3. Immutability of Data
    • 9.3.2.4. High Energy Consumption
  • 9.3.3. Threats
    • 9.3.3.1. Blockchain is Prone to Cyber Attacks
    • 9.3.3.2. Scalability
    • 9.3.3.3. Lack of Regulations Issued by Legal Authorities
  • 9.3.4. Opportunities

10. CASE STUDY: APPLICATIONS OF BLOCKCHAIN IN HEALTHCARE AND OTHER INDUSTRIES

• 10.1. Chapter Overview
• 10.2. Applications of Blockchain Across Various Industries
  • 10.2.1. Blockchain in Healthcare
  • 10.2.2. Blockchain in Banking and Financial Industry
  • 10.2.3. Blockchain in Automotive Industry
  • 10.2.4. Blockchain in Education
  • 10.2.5. Blockchain in Telecom Industry
  • 10.2.6. Blockchain in Transportation
  • 10.2.7. Blockchain in Travel Industry

11. MARKET FORECAST AND OPPORTUNITY ANALYSIS

• 11.1. Chapter Overview
• 11.2. Key Assumptions and Methodology
• 11.3. Blockchain in Drug Discovery and Clinical Trials Market, Till 2035
• 11.4. Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Type of Blockchain
  • 11.4.1. Blockchain in Drug Discovery and Clinical Trials Market for Public Blockchain, Till 2035
  • 11.4.2. Blockchain in Drug Discovery and Clinical Trials Market for Private Blockchain, Till 2035
  • 11.4.3. Blockchain in Drug Discovery and Clinical Trials Market for Hybrid Blockchain, Till 2035
  • 11.4.4. Blockchain in Drug Discovery and Clinical Trials Market for Other Blockchains, Till 2035
• 11.5. Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Type of End-User
  • 11.5.1. Blockchain in Drug Discovery and Clinical Trials Market for Hospitals, Till 2035
  • 11.5.2. Blockchain in Drug Discovery and Clinical Trials Market for Pharmaceutical Industry, Till 2035
  • 11.5.3. Blockchain in Drug Discovery and Clinical Trials Market for Research Institutes, Till 2035
  • 11.5.4. Blockchain in Drug Discovery and Clinical Trials Market for Academic Institutes, Till 2035
• 11.6. Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Key Geographical Regions
  • 11.6.1. Blockchain in Drug Discovery and Clinical Trials Market in North America, Till 2035
  • 11.6.2. Blockchain in Drug Discovery and Clinical Trials Market in Europe, Till 2035
  • 11.6.3. Blockchain in Drug Discovery and Clinical Trials Market in Asia-Pacific, Till 2035
  • 11.6.4. Blockchain in Drug Discovery and Clinical Trials Market in Rest of the World, Till 2035

12. CONCLUDING REMARKS

13. EXECUTIVE INSIGHTS

14. APPENDIX 1: TABULATED DATA

15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

관련자료